Streptokinase increased mortality in acute ischemic stroke

Abstract

TherapeuticsJanuary 1, 1997Streptokinase increased mortality in acute ischemic strokePhilip Bath, MDPhilip Bath, MDKing's College School of Medicine & Dentistry London, England, UK (P.B.)Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/ACPJC-1997-126-1-002 SectionsAboutFull Text ToolsAdd to favoritesDownload CitationsTrack Citations ShareFacebookTwitterLinkedInRedditEmail Source CitationThe Multicenter Acute Stroke Trial—Europe Study Group. Thrombolytic therapy with streptokinase in acute ischemic stroke. N Engl J Med. 1996 Jul 18;335:145-50.References1 Multicentre Acute Stoke Trial-Italy (MAST-I). Lancet 1995;346:1509-14. Google Scholar2 Donnan GA, Davis SM, Chambers BR, et al. Lancet. 1995;345:578-9. Google Scholar3 Hacke W, Kaste M, Fieschi C, et al. JAMA. 1995;274:1017-25. Google Scholar4 The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med. 1995;333:1581-7. Google Scholar5 Wardlaw J, Yamaguchi T, del Zoppo G, Hacke W. The Cochrane Database of Systematic Reviews. 1996; Issue 3. Google Scholar Author, Article, and Disclosure InformationAffiliations: King's College School of Medicine & Dentistry London, England, UK (P.B.) PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails January 1, 1997Volume 126, Issue 1Page: 2KeywordsCerebral arteriesComputed axial tomographyDeath ratesHemorrhageHeparinInfarctionIschemiaIschemic strokeMyocardial infarctionSafetyStrokeSurgery ePublished: 9 March 2020 Issue Published: January 1, 1997 Copyright & PermissionsCopyright © 1997 by American College of Physicians. All Rights Reserved.Loading ...